Jump Financial, LLC Stoke Therapeutics, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.24 - $15.92 $419,550 - $545,689	-34,277 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $378,075 - $600,533	34,277 New	34,277 $463,000
Q4 2022 Feb 13, 2023	BUY	$7.07 - $15.69 $39,252 - $87,110	5,552 Added 55.52%	15,552 $143,000
Q3 2022 Nov 07, 2022	SELL	$12.56 - $22.53 $310,232 - $556,491	-24,700 Reduced 71.18%	10,000 $128,000
Q2 2022 Aug 09, 2022	BUY	$10.36 - $23.93 $205,646 - $475,010	19,850 Added 133.67%	34,700 $458,000
Q1 2022 May 12, 2022	BUY	$17.19 - $26.1 $255,271 - $387,585	14,850 New	14,850 $312,000
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $241,230 - $351,288	-10,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$30.53 - $41.09 $38,650 - $52,019	1,266 Added 14.17%	10,200 $343,000
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $322,338 - $623,682	8,934 New	8,934 $347,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $434M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.